Position in ACAD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$93,483,195
+$23,249,335 QoQ
Shares Held
3,694,988
+17.1% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#7
of 354 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 5%
None 4%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ACAD ranks #18 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,483,195 | 3,694,988 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $70,233,860 | 3,155,160 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $78,019,214 | 2,920,974 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $59,712,178 | 2,798,134 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $51,673,090 | 2,395,600 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $27,495,693 | 1,655,370 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $19,943,511 | 1,086,840 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $12,976,995 | 843,758 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $10,548,686 | 649,150 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $1,150,767 | 36,754 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,945,142 | 93,337 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,451,066 | 102,341 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,451,134 | 130,241 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,038,105 | 316,464 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,830,947 | 356,415 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,945,353 | 492,928 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,530,421 | 641,223 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,410,281 | 660,252 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $4,848,243 | 291,887 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,463,242 | 305,996 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $9,102,678 | 352,817 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,023,878 | 337,147 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $13,497,701 | 327,217 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,118,132 | 311,907 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $12,311,819 | 291,404 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||